Kawagoe, Japan

Sheikh Mohamed Mohamed


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sheikh Mohamed Mohamed: Innovator in Drug Delivery Systems

Introduction

Sheikh Mohamed Mohamed is a notable inventor based in Kawagoe, Japan. He has made significant contributions to the field of drug delivery systems, particularly through his innovative patent that addresses the challenges of penetrating the blood-brain barrier.

Latest Patents

Sheikh Mohamed holds a patent for a composition titled "RGD and transferrin nanoparticle composition." This invention provides a composition that can be utilized for drug delivery systems capable of penetrating the blood-brain barrier while exhibiting low cytotoxicity. The nanoparticle composition comprises nanoparticles to which a first substance and a second substance, each having specificity to a tumor cell, are bound. The first substance is a peptide with an amino acid sequence of arginine-glycine-aspartic acid, while the second substance is an iron-binding protein. The nanoparticles consist of an outer layer and vesicles enveloped by this outer layer, incorporating membrane components such as a PEGylated phospholipid, a fatty acid with a melting point of 30°C or more, and a non-PEGylated phospholipid.

Career Highlights

Sheikh Mohamed is affiliated with Toyo University, where he continues to advance his research in nanoparticle technology and drug delivery systems. His work is pivotal in developing innovative solutions for medical applications, particularly in oncology.

Collaborations

Sheikh Mohamed collaborates with esteemed colleagues, including Toru Maekawa and Sakthikumar Dasappan Nair, to further enhance the impact of his research and inventions.

Conclusion

Sheikh Mohamed Mohamed is a distinguished inventor whose work in drug delivery systems is paving the way for new therapeutic approaches. His innovative patent demonstrates the potential for improved treatment options for patients with challenging medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…